Cargando…
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision. Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more personalized medicine. The endocannabinoid system (ECS) has gained increasing interest due to its involvement in many dif...
Autores principales: | Navarrete, Francisco, García-Gutiérrez, María Salud, Jurado-Barba, Rosa, Rubio, Gabriel, Gasparyan, Ani, Austrich-Olivares, Amaya, Manzanares, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197485/ https://www.ncbi.nlm.nih.gov/pubmed/32395111 http://dx.doi.org/10.3389/fpsyt.2020.00315 |
Ejemplares similares
-
Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
por: García-Gutiérrez, Maria Salud, et al.
Publicado: (2020) -
Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences
por: Navarrete, Francisco, et al.
Publicado: (2020) -
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021) -
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
por: Austrich-Olivares, Amaya, et al.
Publicado: (2022) -
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)